Towerx Effervescent Potassium

Towerx Effervescent Potassium

Towerx Effervescent Potassium Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

WARNINGS:  The administration of potassium salts can produce hyperkalemia and cardiac arrest in patients with impaired mechanisms for potassium excretion.  These reactions most commonly occur in patients receiving potassium intravenously, but may also occur in patients receiving oral potassium.  Potentially fatal hyperkalemia can develop quickly and be asymptomatic.  Patients using potassium salts with chronic renal disease, or any other condition which impairs the excretion of potassium, require especially careful monitoring of serum potassium concentration and appropriate adjustment of dosage.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


1. For therapeutic use in patients with hypokalemia with or without metabolic alkalosis; in digitalis intoxication and in patients with hypokalemic familial
    periodic paralysis.
2. For prevention of potassium depletion when the dietary intake of potassium is inadequate in the following conditions; patients receiving digitalis and
    diuretics for congestive heart failure; hepatic cirrhosis with ascites; states of aldosterone excess with normal renal function; potassium-losing
    nephropathy, and certain diarrheal states.
3. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a
    normal dietary pattern.  Serum potassium should be checked periodically, however, and, if hypokalemia occurs, dietary supplementation with
    potassium-containing foods may be adequate to control milder cases.  In more severe cases supplementation with potassium salts may be


There is currently no drug history available for this drug.

Other Information

DESCRIPTION: An oral potassium supplement.  Each effervescent tablet in solution provides 25 mEq of potassium as supplied by 2.4g potassium bicarbonate with 1.4g Citric Acid, FD and C Yellow #6 Dye, FD and C Yellow #6 Lake,  Natural Orange Flavor, Polyethylene Glycol, Saccharin, Sodium Benzoate, and Sorbitol.

Towerx Effervescent Potassium Manufacturers

  • Tower Laboratories Ltd
    Towerx Effervescent Potassium (Potassium Bicarbonate) Tablet, Effervescent [Tower Laboratories Ltd]

Login To Your Free Account